Application of interim PET-CT in first-line treatment decision-making for lymphoma.

ABSTRACT: Recent advances in lymphoma treatment have significantly improved the survival of patients; however, the current approaches also have varying side effects. To overcome these, it is critical to implement individualized treatment according to the patient's condition. Therefore, the early identification of high-risk groups and targeted treatment are important strategies for prolonging the survival time and improving the quality of life of patients. Interim positron emission tomography-computed tomography (PET-CT) has a high prognostic value, which can reflect chemosensitivity and identify patients for whom treatment may fail under this regimen. To date, many prospective clinical studies on interim PET (iPET)‍-adapted therapy have been conducted. In this review, we focus on the treatment strat

SUBMITTER: Huang L 

PROVIDER: S-EPMC10522568 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature